Webinar May 17th; Extracorporeal Pathogen Adsorption In the Critically III: Sepsis and COVID-19 - ExThera Medical

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
International (English)
Contact

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
International (English)
Contact

menu

Stay up to date

Join our newsletter by filling in the fields below

Name*
Email address*

Contact

ExThera Medical Corporation

757 Arnold Drive, Suite B
Martinez, California 94553

Tel: +1.925.839.2060
Fax: +1.925.839.2075

Navigation

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
International (English)
Contact

Partners / Certifications

Socials

News

ExThera Medical & Fresenius Medical Care Sign Distri...
Patient Enrollment is Complete in the DOD-Funded Study of...
Treatment for critically ill COVID patients results in si...
ExThera Medical and Asahi Kasei Medical Enter into Partne...
How to save a life: Local firefighter with COVID-19 gets ...

© 2023 ExThera Medical | Webdevelopment by webmix

The Seraph 100 Microbind Affinity Blood Filter (Seraph 100) is CE Marked and approved for commercial sale in Europe. | Privacy policy